These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 27245024)

  • 1. [Explore Xueshuan Xinmaining tablet effecting on treatment outcome of coronary heart disease based on propensity score].
    Li Y; Xie YM; Liu Y; Zhao W
    Zhongguo Zhong Yao Za Zhi; 2015 Dec; 40(24):4791-6. PubMed ID: 27245024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis on disease burden and direct medical cost of Xueshuan Xinmaining Tablets in patients with cerebral infarction and coronary heart disease].
    Hu J; Gao SQ; Wang J; Li J; Chen HW; Dai ZQ; Liao X
    Zhongguo Zhong Yao Za Zhi; 2021 May; 46(9):2309-2316. PubMed ID: 34047135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Metabolomics Analysis of Xueshuan Xinmaining Tablet in Blood Stasis Model Rats Using UPLC-Q/TOF-MS.
    Tan J; Wang C; Zhu H; Zhou B; Xiong L; Wang F; Li P; Liu J
    Molecules; 2018 Jul; 23(7):. PubMed ID: 29986394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical Profiling of Xueshuan Xinmaining Tablet by HPLC and UPLC-ESI-Q-TOF/MS.
    Han YX; Wang PF; Zhao M; Chen LM; Wang ZM; Liu XQ; Gao HM; Gong MX; Li H; Zhu JZ; Liu CG
    Evid Based Complement Alternat Med; 2018; 2018():2781597. PubMed ID: 30420891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Explore dengzhan xixin injection effecting on outcome of coronary heart disease based on propensity score].
    Lu PF; Zeng XB; Xie YM; Yang W; Li YY; Yang W; Wang ZG
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3121-8. PubMed ID: 24471339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xueshuan Xinmaining Tablet Treats Blood Stasis through Regulating the Expression of F13a1, Car1, and Tbxa2r.
    Zhang X; Zhang C; Sai J; Li F; Liu J; Li Y; Wang F
    Evid Based Complement Alternat Med; 2015; 2015():704390. PubMed ID: 25821496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment outcomes of parenterally administered dengzhan xixin for treatment of cerebral infaction based on real world hospital injection system data].
    Yang W; Li L; Xie YM; Zhuang Y; Yang W
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3141-9. PubMed ID: 24471342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use propensity score method to analyze data about effectiveness of coronary heart disease treated by kudiezi injection].
    Liao X; Zeng XB; Xie YM; Yang W; Yang W
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3172-9. PubMed ID: 24471347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design.
    Sun X; Guo L; Shang H; Ren M; Wang Y; Huo D; Lei X; Wang H; Zhai J
    Trials; 2015 Nov; 16():496. PubMed ID: 26530718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Exploration of clinical outcomes on coronary heart disease of parenterally administered dengzhan xixin using propensity score].
    Shen H; Yang W; Xie YM; Zeng XB
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3166-71. PubMed ID: 24471346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring pharmacological mechanisms of Xueshuan-Xinmai-Ning tablets acting on coronary heart disease based on drug target-disease gene interaction network.
    Mao X; Xu H; Li S; Su J; Li W; Guo Q; Wang P; Guo R; Xiao X; Zhang Y; Yang H
    Phytomedicine; 2019 Feb; 54():159-168. PubMed ID: 30668365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of blood-activating components from Xueshuan Xinmaining Tablet based on the spectrum-effect relationship and network pharmacology analysis.
    Tan J; Liu J; Wang H; Zhang Y; Lin H; Wang Z; Si H; Zhang Y; Liu J; Li P; Sun K
    RSC Adv; 2020 Mar; 10(16):9587-9600. PubMed ID: 35497256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evalation of Jingzhi Xiaoban Tablet in Improving Heart Function of Coronary Heart Disease Pa- tients by Doppler Tissue Imaging and Speckle Tracking Imaging Technology].
    Wang YA; Yu XJ; Cheng CF; Yang L; Liu F; Zhou MH; Tan Y
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Apr; 36(4):399-402. PubMed ID: 27323608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis effects of shuxuening injection on patient's liver function based on electronic medical data].
    Hao TT; Xie YM; Yang W; Wang YY; Li L; Zhuang Y
    Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3609-15. PubMed ID: 25532405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Activation of Nrf2 and Its Downstream Regulated Genes Mediates the Antioxidative Activities of Xueshuan Xinmaining Tablet in Human Umbilical Vein Endothelial Cells.
    Xiong L; Xie J; Song C; Liu J; Zheng J; Liu C; Zhang X; Li P; Wang F
    Evid Based Complement Alternat Med; 2015; 2015():187265. PubMed ID: 26681964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study on the effect of shuxuening tablet in treatment of coronary heart disease].
    Chen K; Zhou WQ; Gao P
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1996 Jan; 16(1):24-6. PubMed ID: 8732126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness comparison of Jitai tablets versus methadone in community-based drug treatment: a 1-year follow-up study.
    Hao SQ; Zhao M; Zhang RW; Zhang JC; Zhang J; Feng XS
    Addict Behav; 2013 Oct; 38(10):2596-600. PubMed ID: 23827820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical observation on effect of tiaozhi jiangtang tablet on patients with diabetes of blood stasis syndrome: a report of 30 cases].
    Zhang ZX; Zhu LZ; Zhong JB
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Jan; 26(1):72-4. PubMed ID: 16466178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JinQi-Jiangtang tablet, a Chinese patent medicine, for pre-diabetes: a randomized controlled trial.
    Cao H; Ren M; Guo L; Shang H; Zhang J; Song Y; Wang H; Wang B; Li X; Hu J; Wang X; Wang D; Chen J; Li S; Chen L
    Trials; 2010 Mar; 11():27. PubMed ID: 20214831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.